• Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats
  Published on 2023-12-11
  3 years ago
• A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
  Published on 2023-12-11
  3 years ago
• IN MEMORIAM: Roland R. Griffiths, Ph.D
  Published on 2023-12-10
  3 years ago
• Factors influencing JUUL e-cigarette nicotine vapour-induced reward, withdrawal, pharmacokinetics and brain connectivity in rats: sex matters
  Published on 2023-12-06
  3 years ago
• Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer’s disease
  Published on 2023-12-05
  3 years ago
• Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia
  Published on 2023-12-03
  3 years ago
• Greater subjective effects of a low dose of LSD in participants with depressed mood
  Published on 2023-12-01
  3 years ago

« Previous 1 … 103 104 105 106 107 … 143 Next »

• Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine
  Published on 2021-02-11
  5 years ago
• Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats
  Published on 2021-02-11
  5 years ago
• Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
  Published on 2021-02-11
  5 years ago
• Responses to social evaluative stress in regular cannabis smokers
  Published on 2021-02-08
  5 years ago
• Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders
  Published on 2021-02-06
  5 years ago
• Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis
  Published on 2021-02-06
  5 years ago
• Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
  Published on 2021-02-03
  5 years ago

« Previous 1 … 103 104 105 106 107 … 150 Next »

• Emotional cognition subgroups in mood disorders: Associations with familial risk
  Published on 2021-06-05
  5 years ago
• Polygenic risk scores in psychiatry – Large potential but still limited clinical utility
  Published on 2021-06-04
  5 years ago
• Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study
  Published on 2021-06-01
  5 years ago
• Oxytocin blood concentrations in alcohol use disorder: A cross-sectional, longitudinal, and sex-separated study
  Published on 2021-05-31
  5 years ago
• There are no patients without comorbidity
  Published on 2021-05-31
  5 years ago
• Can we expect a rise in suicide rates after the Covid-19 pandemic outbreak?
  Published on 2021-05-30
  5 years ago
• Epidemiology and costs of depressive disorder in Spain: the EPICO study
  Published on 2021-05-29
  5 years ago

« Previous 1 … 103 104 105 106 107 … 168 Next »